Abstract
Treatment of FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) AML is restricted due to toxicity, drug resistance and relapse eventh......
小提示:本篇文献需要登录阅读全文,点击跳转登录